226 related articles for article (PubMed ID: 33085090)
1. Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Hong S; Brazauskas R; Hebert KM; Ganguly S; Abdel-Azim H; Diaz MA; Beattie S; Ciurea SO; Szwajcer D; Badawy SM; Gratwohl AA; LeMaistre C; Aljurf MDSM; Olsson RF; Bhatt NS; Farhadfar N; Yared JA; Yoshimi A; Seo S; Gergis U; Beitinjaneh AM; Sharma A; Lazarus H; Law J; Ulrickson M; Hashem H; Schoemans H; Cerny J; Rizzieri D; Savani BN; Kamble RT; Shaw BE; Khera N; Wood WA; Hashmi S; Hahn T; Lee SJ; Rizzo JD; Majhail NS; Saber W
Cancer; 2021 Feb; 127(4):609-618. PubMed ID: 33085090
[TBL] [Abstract][Full Text] [Related]
2. Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation.
Friend BD; Broglie L; Logan BR; Chhabra S; Bupp C; Schiller G; Beitinjaneh A; Perez MAD; Guilcher GMT; Hashem H; Hildebrandt GC; Krem MM; Lazarus HM; Nishihori T; Nusrat R; Rotz SJ; Wirk B; Wieduwilt M; Pasquini M; Savani BN; Stadtmauer EA; Sorror ML; Thakar MS
Transplant Cell Ther; 2023 Feb; 29(2):123.e1-123.e10. PubMed ID: 36442769
[TBL] [Abstract][Full Text] [Related]
3. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
[TBL] [Abstract][Full Text] [Related]
4. Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy.
Nakaya A; Mori T; Tanaka M; Tomita N; Nakaseko C; Yano S; Fujisawa S; Sakamaki H; Aotsuka N; Yokota A; Kanda Y; Sakura T; Nanya Y; Saitoh T; Kanamori H; Takahashi S; Okamoto S
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1553-9. PubMed ID: 25034961
[TBL] [Abstract][Full Text] [Related]
5. ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation.
Logan AC; Wang Z; Alimoghaddam K; Wong RM; Lai T; Negrin RS; Grumet C; Logan BR; Zhang MJ; Spellman SR; Lee SJ; Miklos DB;
Biol Blood Marrow Transplant; 2015 Apr; 21(4):746-54. PubMed ID: 25572032
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
Aladağ E; Demiroğlu H; Büyükaşık Y; Göker H
Turk J Haematol; 2021 Jun; 38(2):138-144. PubMed ID: 32539316
[TBL] [Abstract][Full Text] [Related]
7. Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.
Barba P; Martino R; Pérez-Simón JA; Fernández-Avilés F; Castillo N; Piñana JL; López-Anglada L; Rovira M; Bosch F; Carreras E; Corral LL; Sierra J; Valcárcel D
Biol Blood Marrow Transplant; 2014 Jan; 20(1):66-72. PubMed ID: 24141006
[TBL] [Abstract][Full Text] [Related]
8. Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
Kołodziejczak M; Gil L; de la Camara R; Styczyński J;
Ann Hematol; 2021 Mar; 100(3):763-777. PubMed ID: 33491135
[TBL] [Abstract][Full Text] [Related]
9. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study.
Sorror ML; Logan BR; Zhu X; Rizzo JD; Cooke KR; McCarthy PL; Ho VT; Horowitz MM; Pasquini MC
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1479-87. PubMed ID: 25862591
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in predicting outcomes for adolescents and young adults with hematologic malignancies undergoing allogeneic stem cell transplant.
Wood W; Deal A; Whitley J; Sharf A; Serody J; Gabriel D; Shea T
Pediatr Blood Cancer; 2011 Sep; 57(3):499-505. PubMed ID: 21384538
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study.
Atallah E; Logan B; Chen M; Cutler C; Deeg J; Jacoby M; Champlin R; Nishihori T; Confer D; Gajewski J; Farnia S; Greenberg P; Warlick E; Weisdorf D; Saber W; Horowitz MM; Rizzo JD
JAMA Oncol; 2020 Apr; 6(4):486-493. PubMed ID: 31830234
[TBL] [Abstract][Full Text] [Related]
12. Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation.
Armenian SH; Xiao M; Berano Teh J; Lee B; Chang HA; Mascarenhas K; Lee S; Iukuridze A; Xie JJ; Scott JM; Jones LW; Lennie Wong F; Forman SJ; Nakamura R
J Natl Cancer Inst; 2019 Aug; 111(8):837-844. PubMed ID: 30951603
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
[TBL] [Abstract][Full Text] [Related]
15. Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis.
Blue BJ; Brazauskas R; Chen K; Patel J; Zeidan AM; Steinberg A; Ballen K; Kwok J; Rotz SJ; Perez MAD; Kelkar AH; Ganguly S; Wingard JR; Lad D; Sharma A; Badawy SM; Lazarus HM; Hashem H; Szwajcer D; Knight JM; Bhatt NS; Page K; Beattie S; Arai Y; Liu H; Arnold SD; Freytes CO; Abid MB; Beitinjaneh A; Farhadfar N; Wirk B; Winestone LE; Agrawal V; Preussler JM; Seo S; Hashmi S; Lehmann L; Wood WA; Rangarajan HG; Saber W; Majhail NS
Transplant Cell Ther; 2023 Nov; 29(11):709.e1-709.e11. PubMed ID: 37482244
[TBL] [Abstract][Full Text] [Related]
16. The Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.
Shibasaki Y; Suwabe T; Katagiri T; Tanaka T; Kobayashi H; Fuse K; Ushiki T; Sato N; Yano T; Kuroha T; Hashimoto S; Narita M; Furukawa T; Sone H; Masuko M
Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28871665
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation.
Acosta-Medina AA; Baranwal A; Johnson IM; Kharfan-Dabaja MA; Murthy H; Palmer JM; Sproat L; Mangaonkar A; Shah MV; Hogan WJ; Litzow MR; Tefferi A; Alkhateeb HB
Transplant Cell Ther; 2023 Jun; 29(6):360.e1-360.e8. PubMed ID: 36773650
[TBL] [Abstract][Full Text] [Related]
18. Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups.
Rowan CM; Pike F; Cooke KR; Krance R; Carpenter PA; Duncan C; Jacobsohn DA; Bollard CM; Cruz CRY; Malatpure A; Farag SS; Renbarger J; Liu H; Bakoyannis G; Hanash S; Paczesny S
Blood; 2020 Apr; 135(17):1428-1437. PubMed ID: 31972009
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.
Michelis FV; Gupta V; Zhang MJ; Wang HL; Aljurf M; Bacher U; Beitinjaneh A; Chen YB; DeFilipp Z; Gale RP; Kebriaei P; Kharfan-Dabaja M; Lazarus HM; Nishihori T; Olsson RF; Oran B; Rashidi A; Rizzieri DA; Tallman MS; de Lima M; Khoury HJ; Sandmaier BM; Weisdorf D; Saber W;
Cancer; 2017 Jun; 123(11):2035-2042. PubMed ID: 28117898
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.
Saad A; Mahindra A; Zhang MJ; Zhong X; Costa LJ; Dispenzieri A; Drobyski WR; Freytes CO; Gale RP; Gasparetto CJ; Holmberg LA; Kamble RT; Krishnan AY; Kyle RA; Marks D; Nishihori T; Pasquini MC; Ramanathan M; Lonial S; Savani BN; Saber W; Sharma M; Sorror ML; Wirk BM; Hari PN
Biol Blood Marrow Transplant; 2014 Mar; 20(3):402-408.e1. PubMed ID: 24342394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
